Monoclonal antibodies for the treatment of COVID-19 in a patient with high-risk acute leukaemia

被引:6
|
作者
Saultier, Paul [1 ,2 ]
Ninove, Laetitia [3 ,4 ]
Szepetowski, Sarah [1 ]
Veneziano, Mathilde [1 ]
Visentin, Sandrine [1 ]
Barlogis, Vincent [1 ]
Saba Villarroel, Paola Mariela [3 ]
Amroun, Abdennour [3 ,4 ]
Loosveld, Marie [5 ]
de Lamballerie, Xavier [3 ,4 ]
Chambost, Herve [1 ,2 ]
机构
[1] La Timone Childrens Hosp, APHM, Dept Pediat Hematol Immunol & Oncol, Marseille, France
[2] Aix Marseille Univ, INSERM, INRAe, C2VN, Aix En Provence, France
[3] UVE, Unite Virus Emergents, Noumea, New Caledonia
[4] Aix Marseille Univ, Hop Univ Marseille, INSERM 1207, IRD 190, Marseille, France
[5] La Timone Hosp, AP HM, Hematol Lab, Marseille, France
关键词
hematologic neoplasms; COVID-19; SARS-CoV-2; COVID-19 drug treatment; monoclonal antibodies; SARS-COV-2;
D O I
10.1111/bjh.17756
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E1 / E3
页数:3
相关论文
共 50 条
  • [1] A High-Risk Patient With COVID-19 Vaccine Hesitancy Successfully Treated With Monoclonal Antibodies Through Two Major Surges
    Gurjar, Hitesh
    Ghazanfar, Haider
    Haider, Asim
    Hernandez, Nolberto
    Jyala, Abhilasha
    Chilimuri, Sridhar
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (02)
  • [2] Single Site Experience of the use of Monoclonal Antibodies for the Treatment of COVID-19 in High-risk Pediatric and Young Adult Patients
    Bahakel, Hannah
    Murphy, Catherine
    Frenck, Robert W.
    Grimley, Michael S.
    Marsh, Rebecca A.
    Paulsen, Grant C.
    Haslam, David B.
    Phillips, Christine L.
    Courter, Joshua
    Spearman, Paul
    Schulert, Grant
    Danziger-Isakov, Lara
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2022, 41 (12) : 985 - 988
  • [3] Neutralizing monoclonal antibodies for treatment of COVID-19
    Taylor, Peter C.
    Adams, Andrew C.
    Hufford, Matthew M.
    de la Torre, Inmaculada
    Winthrop, Kevin
    Gottlieb, Robert L.
    NATURE REVIEWS IMMUNOLOGY, 2021, 21 (06) : 382 - 393
  • [4] Monoclonal Antibodies for Prevention and Treatment of COVID-19
    Marovich, Mary
    Mascola, John R.
    Cohen, Myron S.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (02): : 131 - 132
  • [5] Neutralizing monoclonal antibodies for treatment of COVID-19
    Peter C. Taylor
    Andrew C. Adams
    Matthew M. Hufford
    Inmaculada de la Torre
    Kevin Winthrop
    Robert L. Gottlieb
    Nature Reviews Immunology, 2021, 21 : 382 - 393
  • [6] The Relevance of Monoclonal Antibodies in the Treatment of COVID-19
    Torrente-Lopez, Anabel
    Hermosilla, Jesus
    Navas, Natalia
    Cuadros-Rodriguez, Luis
    Cabeza, Jose
    Salmeron-Garcia, Antonio
    VACCINES, 2021, 9 (06)
  • [7] Early Treatment with Monoclonal Antibodies or Convalescent Plasma Reduces Mortality in Non-Vaccinated COVID-19 High-Risk Patients
    Thuemmler, Laura
    Lindemann, Monika
    Horn, Peter A.
    Lenz, Veronika
    Konik, Margarethe
    Gaeckler, Anja
    Boss, Kristina
    Theodoropoulos, Fotis
    Besa, Vasiliki
    Taube, Christian
    Brenner, Thorsten
    Witzke, Oliver
    Krawczyk, Adalbert
    Rohn, Hana
    VIRUSES-BASEL, 2023, 15 (01):
  • [8] Monoclonal Antibody Treatment of Breakthrough COVID-19 in Fully Vaccinated Individuals with High-Risk Comorbidities
    Bierle, Dennis M.
    Ganesh, Ravindra
    Tulledge-Scheitel, Sidna
    Hanson, Sara N.
    Arndt, Lori L.
    Wilker, Caroline G.
    Razonable, Raymund R.
    JOURNAL OF INFECTIOUS DISEASES, 2022, 225 (04): : 598 - 602
  • [9] Evaluation of Monoclonal Antibodies in Preventing Hospitalizations, Emergency Department Visits, and Mortality in High-Risk COVID-19 Patients
    Milam, Ashlee N.
    Doan, Diana T.
    Childress, Darrell T.
    Durham, Spencer H.
    JOURNAL OF PHARMACY TECHNOLOGY, 2022, 38 (03) : 169 - 173
  • [10] Monoclonal Antibodies for COVID-19
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2022, 64 (1642): : 16 - 16